Your session is about to expire
← Back to Search
Smoking Cessation Program for Tobacco-Related Cancer
Study Summary
This trial looks at whether a smoking cessation program can help high-risk women in rural communities quit smoking. Cigarette smoking is a major risk factor for cervical cancer in women, and these programs may help reduce rates of smoking and cervical cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I'm sorry, could you please provide more context or information about this criterion? It seems incomplete.I provide care to women who smoke.I am female.You live in one of the Appalachian areas included in this study.I'm sorry, but the criterion you provided is incomplete. Please provide the full criterion so I can summarize it for you.I'm sorry, but "HEALTH SYSTEM/CLINIC" is not a criterion. Could you please provide more context or information?I smoke at least 5 cigarettes daily.I am between 18 and 64 years old.You are a healthcare provider who takes care of patients.You receive medical care from one of the healthcare systems involved in the study.
- Group 1: Arm II (delayed arm)
- Group 2: Arm I (early arm)
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there currently any opportunities to join this experiment?
"Verified; this clinical trial is currently accepting participants. Its initial posting on January 30th, 2021 has been followed by a most recent update occurring April 23rd 2022, as indicated in the records hosted on clinicaltrials.gov."
Do I meet the qualifications to join this research program?
"This clinical trial seeks 810 female patients, aged 18 to 64, with a diagnosis of tobacco-related carcinoma. Eligibility requirements limit enrollees to those coming from qualified Appalachian health systems and who are receiving care by a participating provider. Additionally, participants must be smokers that consume at least 5 cigarettes daily for an indication of nicotine dependence."
Does this trial permit individuals aged 40 or older to participate?
"According to the requirements for participation, eligible candidates must be between 18 and 64 years of age."
Has the FDA given its seal of approval to Tobacco Cessation Counseling?
"The safety of Tobacco Cessation Counseling was rated a 3 on our Power scale as it has been approved and is in its fourth phase of clinical trials."
To what extent is this clinical trial being administered to participants?
"This medical trial requires 810 suitable participants, who meet the established prerequisite criteria. Potential enrollees can present themselves for inclusion at West virginia University in Morgantown or Ohio State University Comprehensive Cancer Center in Columbus, Ohio."
How prevalent is the implementation of this research in American healthcare facilities?
"This scientific investigation is open to participants from West virginia University, Ohio State University Comprehensive Cancer Center, and the University of Kentucky/Markey Cancer Centre. Additionally, there are 4 other clinical trial sites accepting patients."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger